Home/Filings/4/0001162194-23-000008
4//SEC Filing

JOG VIKRAM 4

Accession 0001162194-23-000008

CIK 0001162194other

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 8:44 PM ET

Size

23.6 KB

Accession

0001162194-23-000008

Insider Transaction Report

Form 4
Period: 2023-02-21
JOG VIKRAM
CHIEF FINANCIAL OFFICER
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2023-02-212,2380 total
    Common Stock (2,238 underlying)
  • Award

    Restricted Stock Units

    2023-02-213,13028,176 total
    Common Stock (3,130 underlying)
  • Exercise/Conversion

    Common Stock

    2023-02-21+2,391243,199 total
  • Tax Payment

    Common Stock

    2023-02-21$2.03/sh28,707$58,275217,622 total
  • Exercise/Conversion

    Restricted Stock Units

    2023-02-2150,0000 total
    Common Stock (50,000 underlying)
  • Exercise/Conversion

    Common Stock

    2023-02-21+50,000221,904 total
  • Exercise/Conversion

    Common Stock

    2023-02-21+16,666238,570 total
  • Exercise/Conversion

    Common Stock

    2023-02-21+2,238240,808 total
  • Exercise/Conversion

    Common Stock

    2023-02-21+3,130246,329 total
  • Exercise/Conversion

    Restricted Stock Units

    2023-02-2116,666183,334 total
    Common Stock (16,666 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2023-02-212,3919,563 total
    Common Stock (2,391 underlying)
Holdings
  • Common Stock

    (indirect: See Footnote)
    52,061
Footnotes (7)
  • [F1]Shares held indirectly by the Vikram and Pratima Family Trust U/A dated June 23, 2009.
  • [F2]Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock.
  • [F3]The Restricted Stock Units vest in full on February 20, 2023 or the date the Reporting Person's employment with the Company is terminated involuntarily without "cause."
  • [F4]On December 20, 2022, the Reporting Person was granted 200,000 Restricted Stock Units vesting in quarterly installments over the course of three years commencing February 20, 2023.
  • [F5]On February 19, 2019, the Reporting Person was granted 35,787 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.
  • [F6]On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the underlying shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter.
  • [F7]On April 20, 2021, the Reporting Person was granted 50,089 Restricted Stock Units vesting as to 1/4 of the total number of shares on May 20, 2022, and as to 1/16th of the total number of shares each quarter thereafter.

Issuer

STANDARD BIOTOOLS INC.

CIK 0001162194

Entity typeother

Related Parties

1
  • filerCIK 0001222641

Filing Metadata

Form type
4
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 8:44 PM ET
Size
23.6 KB